Felix Gonzalez Lopez De Turiso

USPTO Granted Patents = 26 (Patent Applications = 19)

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 13 (Patent Applications = 25)

Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 79(Granted Patents)

Location History:

San Mateo, CA (US) (2012 - 2018)
Cambridge, MA (US) (2017 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2012-2025

where 'Filed Patents' based on already Granted Patents

26 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12404263 - ASK1 inhibiting agents (2025-09-02),

2. 11999715 - ASK1 inhibiting agents (2024-06-04),

3. 11897898 - Pyridine macrocycle compounds as ASK1 inhibiting agents (2024-02-13),

4. 11814362 - ASK1 inhibiting agents (2023-11-14),

5. 11780826 - Bisamide sarcomere activating compounds and uses thereof (2023-10-10),

6. 11407721 - CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer (2022-08-09),

7. 11306107 - Compounds that inhibit MCL-1 protein (2022-04-19),

8. 11299479 - Bisamide sarcomere activating compounds and uses thereof (2022-04-12),

9. 11168095 - ASK1 inhibiting agents (2021-11-09),

10. 10899746 - Bisamide sarcomere activating compounds and uses thereof (2021-01-26),

11. 10723720 - Bisamide sarcomere activating compounds and uses therof (2020-07-28),

12. 9873704 - Heterocyclic compounds and their uses (2018-01-23),

13. 9873701 - Heterocyclic compounds and their uses (2018-01-23),

14. 9593129 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer (2017-03-14),

15. 9376425 - Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer (2016-06-28),

Title: Innovator Spotlight: Felix Gonzalez Lopez De Turiso

Introduction:

Felix Gonzalez Lopez De Turiso is a prolific inventor based in San Mateo, CA (US) with an impressive track record in the field of pharmaceuticals. With 21 patents to his name, his contributions to the world of medicine and cancer treatment are truly remarkable.

Latest Patents:

Two of his latest patents showcase his innovative approach to developing life-saving compounds. The first patent focuses on Bisamide sarcomere activating compounds and their therapeutic uses, while the second patent delves into the use of CIS-morpholinone and other compounds as MDM2 inhibitors for cancer treatment.

Career Highlights:

Felix Gonzalez Lopez De Turiso has made significant contributions to the pharmaceutical industry through his work with renowned companies such as Amgen Inc. and Cytokinetics, Inc. His expertise and dedication have been instrumental in advancing the field of cancer research and drug development.

Collaborations:

Throughout his career, Felix Gonzalez Lopez De Turiso has collaborated with esteemed professionals in the industry, including his coworkers Michael G Johnson and Timothy David Cushing. These collaborations have led to groundbreaking discoveries and the development of novel treatments for various medical conditions.

Conclusion:

In conclusion, Felix Gonzalez Lopez De Turiso is a visionary inventor whose innovative research and patents have had a profound impact on the field of pharmaceuticals. His commitment to advancing medical science and improving patient outcomes continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.